Although estrogen is used as a treatment for many women, it is also attributed to be a carcinogen. The National Toxicology Program voted that steroidal estrogen should be listed as a cancer-causing substance because of its association with endometrial and breast cancer. Steroidal estrogen is used in post-menopausal treatments and birth control pills.
Doctors have known about the cancer link and usually prescribe post-menopausal estrogen pills along with another hormone called progestin. This combination lowers the risk of endometrial cancer.
The National Institutes of Health updates the federal list of proven and suspected cancer-causing substances every two years.
Information from the AP.
Obituary: In Memory of SMART4TB and Project ACCELERATE
March 14th 2025In this remembrance of SMART4TB and Project ACCLERATE, 2 global health initiatives, Heather Stoltzfus, MPH, RN, CIC, explains what they are and why they serve as a warning of what has been lost and what more could be lost in the future.
The Art of Wise Leadership in Infection Control and Quality Management
March 14th 2025Discover how wise leadership in infection control transforms challenges into opportunities, fosters teamwork, and safeguards patient safety through emotional intelligence, strategic vision, and inspiring action.
The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases
March 12th 2025Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.
Standing Up for Science: A Rally Participant’s Perspective
March 11th 2025Infection Control Today's Editorial Advisory Board member and contributing editor, Heather Stoltzfus, MPH, RN, CIC, recently joined the Stand Up for Science rally in Washington, DC. She gives a first-person perspective on the rally and the rally-goers' strong message.